Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device

Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device

The FIH study was designed to demonstrate the safety and feasibility of the CAPTIS device in patients undergoing notes Filterlex Medical.

Next →
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • Medical Specialists Subscribe
  • Industry Subscribe
  • Privacy Statement
    • Cookie Policy
  • Contact
  • ADVERTISE
  • ADVERTISE

© 2026 All rights Reserved. Medical Device News Magazine, a Division of PTM Healthcare Marketing, Inc.